Curaleaf Holdings (CURLF) Non-Current Deferred Tax Liability (2019 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Non-Current Deferred Tax Liability of $235.1 million in Q4 2025, down 11.79% quarter-over-quarter from $266.5 million in Q4 2024, and down 11.79% on a YoY basis from $266.5 million in Q4 2024.

Curaleaf Holdings (CURLF) Non-Current Deferred Tax Liability (2019 - 2025) Analysis & Trends

Curaleaf Holdings' Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $235.1 million for Q4 2025.

  • In Q4 2025, Non-Current Deferred Tax Liability fell 11.79% year-over-year to $235.1 million; the TTM figure through Dec 2025 stood at $235.1 million (down 11.79% YoY), while the FY2025 annual figure was $235.1 million, down 11.79% from the prior year.
  • Non-Current Deferred Tax Liability was $235.1 million for Q4 2025 at Curaleaf Holdings, down from $266.5 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $342.6 billion in Q1 2022 to a low of $222.6 million in Q1 2021.
  • Historically, Non-Current Deferred Tax Liability has averaged $24.7 billion across 5 years, with a median of $302.3 million in 2021.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability soared 153837.26% in 2022, then decreased 11.79% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $257.8 million in 2021, then advanced by 28.91% to $332.3 million in 2022, then fell by 9.38% to $301.1 million in 2023, then declined by 11.5% to $266.5 million in 2024, then declined by 11.79% to $235.1 million in 2025.
  • The last three Non-Current Deferred Tax Liability figures came in at $235.1 million (Q4 2025), $266.5 million (Q4 2024), and $276.2 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Curaleaf Holdings - - 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 235.08 Mn
Dec 31, 2025 235.08 Mn
Dec 31, 2024 266.49 Mn
Dec 31, 2024 266.49 Mn
Sep 30, 2024 276.22 Mn
Sep 30, 2024 276.22 Mn
Jun 30, 2024 285.59 Mn
Jun 30, 2024 285.59 Mn
Dec 31, 2023 301.13 Mn
Dec 31, 2023 301.13 Mn
Sep 30, 2023 311.04 Mn
Sep 30, 2023 311.04 Mn
Jun 30, 2023 318.21 Mn
Jun 30, 2023 318.21 Mn
Sep 30, 2022 332.31 Mn
Sep 30, 2022 332.31 Mn
Jun 30, 2022 334.81 Mn
Jun 30, 2022 334.81 Mn
Mar 31, 2022 342.61 Bn
Mar 31, 2022 342.61 Bn